Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers

Fluorescent tracers are being tested in clinical trials to improve detection of tumor margins, but procedures are not standardised. Here, the authors develop an analytical framework that is compatible with the workflow in the operating theatre, and show that it leads to an 88% increase in intraopera...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marjory Koller, Si-Qi Qiu, Matthijs D. Linssen, Liesbeth Jansen, Wendy Kelder, Jakob de Vries, Inge Kruithof, Guo-Jun Zhang, Dominic J. Robinson, Wouter B. Nagengast, Annelies Jorritsma-Smit, Bert van der Vegt, Gooitzen M. van Dam
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
Q
Acceso en línea:https://doaj.org/article/3ed830983e42469387cbdb1c666bbe45
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3ed830983e42469387cbdb1c666bbe45
record_format dspace
spelling oai:doaj.org-article:3ed830983e42469387cbdb1c666bbe452021-12-02T15:33:58ZImplementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers10.1038/s41467-018-05727-y2041-1723https://doaj.org/article/3ed830983e42469387cbdb1c666bbe452018-09-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-05727-yhttps://doaj.org/toc/2041-1723Fluorescent tracers are being tested in clinical trials to improve detection of tumor margins, but procedures are not standardised. Here, the authors develop an analytical framework that is compatible with the workflow in the operating theatre, and show that it leads to an 88% increase in intraoperative detection of tumor margins in patients with breast cancer.Marjory KollerSi-Qi QiuMatthijs D. LinssenLiesbeth JansenWendy KelderJakob de VriesInge KruithofGuo-Jun ZhangDominic J. RobinsonWouter B. NagengastAnnelies Jorritsma-SmitBert van der VegtGooitzen M. van DamNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-11 (2018)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Marjory Koller
Si-Qi Qiu
Matthijs D. Linssen
Liesbeth Jansen
Wendy Kelder
Jakob de Vries
Inge Kruithof
Guo-Jun Zhang
Dominic J. Robinson
Wouter B. Nagengast
Annelies Jorritsma-Smit
Bert van der Vegt
Gooitzen M. van Dam
Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers
description Fluorescent tracers are being tested in clinical trials to improve detection of tumor margins, but procedures are not standardised. Here, the authors develop an analytical framework that is compatible with the workflow in the operating theatre, and show that it leads to an 88% increase in intraoperative detection of tumor margins in patients with breast cancer.
format article
author Marjory Koller
Si-Qi Qiu
Matthijs D. Linssen
Liesbeth Jansen
Wendy Kelder
Jakob de Vries
Inge Kruithof
Guo-Jun Zhang
Dominic J. Robinson
Wouter B. Nagengast
Annelies Jorritsma-Smit
Bert van der Vegt
Gooitzen M. van Dam
author_facet Marjory Koller
Si-Qi Qiu
Matthijs D. Linssen
Liesbeth Jansen
Wendy Kelder
Jakob de Vries
Inge Kruithof
Guo-Jun Zhang
Dominic J. Robinson
Wouter B. Nagengast
Annelies Jorritsma-Smit
Bert van der Vegt
Gooitzen M. van Dam
author_sort Marjory Koller
title Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers
title_short Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers
title_full Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers
title_fullStr Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers
title_full_unstemmed Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers
title_sort implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/3ed830983e42469387cbdb1c666bbe45
work_keys_str_mv AT marjorykoller implementationandbenchmarkingofanovelanalyticalframeworktoclinicallyevaluatetumorspecificfluorescenttracers
AT siqiqiu implementationandbenchmarkingofanovelanalyticalframeworktoclinicallyevaluatetumorspecificfluorescenttracers
AT matthijsdlinssen implementationandbenchmarkingofanovelanalyticalframeworktoclinicallyevaluatetumorspecificfluorescenttracers
AT liesbethjansen implementationandbenchmarkingofanovelanalyticalframeworktoclinicallyevaluatetumorspecificfluorescenttracers
AT wendykelder implementationandbenchmarkingofanovelanalyticalframeworktoclinicallyevaluatetumorspecificfluorescenttracers
AT jakobdevries implementationandbenchmarkingofanovelanalyticalframeworktoclinicallyevaluatetumorspecificfluorescenttracers
AT ingekruithof implementationandbenchmarkingofanovelanalyticalframeworktoclinicallyevaluatetumorspecificfluorescenttracers
AT guojunzhang implementationandbenchmarkingofanovelanalyticalframeworktoclinicallyevaluatetumorspecificfluorescenttracers
AT dominicjrobinson implementationandbenchmarkingofanovelanalyticalframeworktoclinicallyevaluatetumorspecificfluorescenttracers
AT wouterbnagengast implementationandbenchmarkingofanovelanalyticalframeworktoclinicallyevaluatetumorspecificfluorescenttracers
AT anneliesjorritsmasmit implementationandbenchmarkingofanovelanalyticalframeworktoclinicallyevaluatetumorspecificfluorescenttracers
AT bertvandervegt implementationandbenchmarkingofanovelanalyticalframeworktoclinicallyevaluatetumorspecificfluorescenttracers
AT gooitzenmvandam implementationandbenchmarkingofanovelanalyticalframeworktoclinicallyevaluatetumorspecificfluorescenttracers
_version_ 1718386955269439488